Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Mastology (Online) ; 30: 1-7, 2020.
Article in English | LILACS-Express | LILACS | ID: biblio-1141092

ABSTRACT

Fibroadenomas (FAs) are benign fibro-epithelial tumours of the breast characterized by being biphasic and having stromal and epithelial components. It is estimated that FAs affect more than 20 percent of the general population aged 16­40 years old. Complex FAs are a sub-type of fibroadenoma presenting one or more pathological characteristics, such as epithelial calcifications, apocrine metaplasias, sclerosing adenoma and cysts larger than 3 mm. According to studies elsewhere, women with complex FAs are 3.1 times more likely to develop breast cancer. The objective of the present study was to map the scientific production of articles on complex FA in the international literature. The ISI Web of Knowledge (Web of Science), one of the main scientific databases in the world, was searched with the following terms: ("complex" and "fibroadenoma") or ("fibroadenoma" and "complex"). Only articles published between 1981 and 2019 were considered for a bibliometric review, in which 160 articles from 126 different periodicals were identified after using refinement filters. Moreover, a clinical case was also discussed based on the patient's medical record and interview

2.
Rev. Col. Bras. Cir ; 38(1): 79-80, jan.-fev. 2011. ilus
Article in Portuguese | LILACS | ID: lil-584133

ABSTRACT

The authors report a case of a male patient in his forties with progressive abdominal pain associated with weight loss, dyspnea, and edema of the inferior limbs, culminating in a surgical acute abdomen. A segmental enterectomy containing a lesion of about 10cm in diameter was performed. It was later confirmed, by means of immuno-hystochemistry, as being a Gastrointestinal Stromal Tumor of high biological aggressiveness. Etiology, diagnosis, classification, prognosis and therapeutic with Imatinib Mesylate - STI-571 (Glivec® - Novartis) are hence discussed.


Subject(s)
Humans , Male , Middle Aged , Gastrointestinal Stromal Tumors , Jejunal Neoplasms , Gastrointestinal Stromal Tumors/pathology , Gastrointestinal Stromal Tumors/surgery , Jejunal Neoplasms/pathology , Jejunal Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL